StonvexLoading…
StonvexStonvexStonvexCore line items from CHWY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-01 | Q4 2025 2025-11-02 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|
Revenue | $12.60B | $9.34B | $6.22B | $3.12B |
Operating Income | $254.30M | $211.80M | $146.60M | $76.90M |
Net Income | $222.80M | $183.60M | $124.40M | $62.40M |
EPS (Diluted) | $0.52 | $0.43 | $0.29 | $0.15 |
Total Assets | $3.37B | $3.29B | $3.12B | $3.06B |
Total Liabilities | $2.87B | $2.83B | $2.73B | $2.68B |
Cash & Equivalents | $860.10M | $675.40M | $591.80M | $616.40M |
Free Cash Flow OCF − CapEx | $562.40M | $330.40M | $154.60M | $48.70M |
Shares Outstanding | 425.80M | 426.40M | 426.80M | 425.30M |